|
|
|
|
|
|
|
09.05.25 - 22:07
|
PriceSmart Announces CFO Transition Plan (PR Newswire)
|
|
Gualberto Hernandez to be appointed as CFO; Michael McCleary to Retire SAN DIEGO, May 9, 2025 /PRNewswire/ -- PriceSmart, Inc. ("PriceSmart" or the "Company") (NASDAQ: PSMT) today announced the appointment of Gualberto Hernandez as Executive Vice President and Chief Financial Officer......
|
|
|
|
|
|
|
|
|
|
|
03.03.25 - 22:03
|
PriceSmart Announces CEO Transition Plan (PR Newswire)
|
|
Robert Price to Step Down as Interim CEO; Will Become Executive Chairman of the Board of Directors David Price Named CEO to Succeed Robert Price SAN DIEGO, March 3, 2025 /PRNewswire/ -- PriceSmart, Inc. ("PriceSmart" or the "Company") (NASDAQ: PSMT) today announced that Robert Price has......
|
|
|
24.02.25 - 14:03
|
Industry Veteran and VC Investor Strengthen the BTB Therapeutics Board (Business Wire)
|
|
ESCONDIDO, Calif.--(BUSINESS WIRE)--BTB Therapeutics, Inc., a clinical-stage drug development company developing a non-opioid pain medicine ENDOPIN, today announced the election of David R. Snyder, Esq. and Nobuhiro Yagi, PhD to its board of directors.
Mr. Snyder retired as a partner with Pillsbury Winthrop Shaw Pittman LLP effective January 1, 2025. Mr. Snyder was a lawyer in the firm's Corporate & Securities practice for over 30 years, focusing on corporate finance and mergers and acquisitions for both private and public companies. For the past several years he has held an adjunct faculty appointment at the University of San Diego School of Law. Mr. Snyder holds a Doctor of Law degree from Cornell University and a Bachelor of Arts from Michigan State University. He is NACD Directorship Certified®. Mr. Snyder has served on the Board of Directors of PriceSmart, Inc. (Nasdaq: PSMT) since 2021 and currently is Vice Chairman and Lead Independent Director.
Dr. Yagi is Executive Officer and General Manager o...
|
|
16.02.25 - 21:12
|
XFRA : DIVIDEND/INTEREST INFORMATION - 18.02.2025 - US7415111092 (XETRA)
|
|
Das Instrument PS8 US7415111092 PRICESMART INC. DL-,0001 EQUITY wird cum Dividende/Zinsen gehandelt am 17.02.2025 und ex Dividende/Zinsen am 18.02.2025
The instrument PS8 US7415111092 PRICESMART INC. DL-,0001 EQUITY has its pre-dividend/interest day on 17.02.2025 and its ex-dividend/interest day on 18.02.2025...
|
|